Israeli Venture Capital Peregrine Sells 30% of Neovasic for $12 Million

Israeli venture capital firm Peregrine Ventures has unloaded 30% of its ownership in the Canadian medical device company Neovasic for $12 million. Fidelity purchased the stake in Neovasic taking 2 million of More...